The launch event in Shanghai also marked the unveiling of a new suite of annual healthcare services aimed at improving accessibility, efficiency, and continuity of care.
The company’s updated offerings revolve around three pillars:
These are designed to meet rising demand for integrated medical services among both consumers and corporate clients.
Michael Guo Xiaotao, co-CEO and executive director of Ping An Group, said the initiative strengthens Ping An’s focus on financial services and health management.
“By integrating high-quality domestic and international resources, building the flagship internet healthcare platform Ping An Good Doctor, and establishing our self-operated medical institution, PKU Healthcare Group, Ping An has initially completed the construction of a comprehensive health network, offering ‘online, in-store, in-home, and in-company’ services,” he said.
Ping An Good Doctor operates a broad digital healthcare ecosystem, with 400 million registered users and 20 million subscribers to its family doctor service. The platform collaborates with 2,100 companies, providing medical services to over 5 million employees.
Li Dou (pictured), chairman and CEO of the health tech subsidiary, described the rebrand as an extension of Ping An’s long-standing insurance-healthcare synergy.
“The brand name ‘Ping An Good Doctor’ embodies the company’s founding mission to ‘bridge doctors and patients with professionalism and safeguard everyone’s health,’” he said.
The platform includes access to more than 50,000 physicians across 29 medical disciplines and is linked to 105,000 health service partners, 235,000 pharmacies, and 4,000 hospitals.
Notably, Ping An has launched a “zero-distance” consultation feature enabling connections with over 3,000 medical experts within three hours.
A key component of Ping An’s upgraded strategy involves AI-powered healthcare tools.
At the event, the firm introduced a “7+N+1” AI medical framework combining legacy systems with new intelligent service modules. These include tools for:
Among the highlighted tools is “Ping An Xin Yi,” an AI doctor designed to assist with diagnosis and treatment planning for complex conditions.
Another system, “Dr. An,” complements human-led services by offering always-available assistance in medical inquiries, interpretation of test results, and patient education.
Ping An also revealed its intention to expand AI collaboration in oncology and chronic care.
Li Yexiong, professor at the Cancer Hospital of the Chinese Academy of Medical Sciences, said AI will play a greater role in evidence-based medical decision-making.
“In the future, oncology expert teams will collaborate with Ping An Group and Ping An Good Doctor to explore the diverse clinical applications of the AI-MDT model, expanding from breast cancer diagnosis and treatment to multi-disease intelligent systems, helping standardise medical practices and ensure quality and safety,” he said.
Ping An Insurance Group’s financial results for Q1 2025 underscore the relevance of its health-tech push.
Operating profit attributable to shareholders rose 2.4% year-over-year to RMB37.91 billion, while its life and health segment posted a 34.9% increase in new business value, totalling RMB12.89 billion.
Ping An Health, the group’s healthcare-focused business unit, saw its revenue climb 25.8% to RMB1.06 billion in the first quarter. The group reported nearly 245 million retail customers and high policy retention rates, with 98% of customers holding four or more policies.
